Answer
No, romiplostim must not be used outside clinical trials for thrombocytopenia caused by myelodysplastic syndromes or any cause other than immune thrombocytopenia (ITP).
Sources for this answer
- Nplate 250 micrograms powder and solvent for solution for injectionAmgen Ltd · emc · SmPC §4.4 Special warnings and precautions for use · Version 21Document updated
Sources checked